196 related articles for article (PubMed ID: 26444738)
21. Is there a problem with ezetimibe or just ENHANCEd hype?
Whayne TF
Angiology; 2008 Dec-2009 Jan; 59(6):661-3. PubMed ID: 18796445
[No Abstract] [Full Text] [Related]
22. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW
Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326
[TBL] [Abstract][Full Text] [Related]
23. Effects of simvastatin and ezetimibe in lowering low-density lipoprotein cholesterol in subjects with type 1 and type 2 diabetes mellitus.
Ciriacks K; Coly G; Krishnaswami S; Patel SB; Kidambi S
Metab Syndr Relat Disord; 2015 Mar; 13(2):84-90. PubMed ID: 25490061
[TBL] [Abstract][Full Text] [Related]
24. A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial.
Pearson TA; Denke MA; McBride PE; Battisti WP; Brady WE; Palmisano J
Mayo Clin Proc; 2005 May; 80(5):587-95. PubMed ID: 15887425
[TBL] [Abstract][Full Text] [Related]
25. Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).
Bohula EA; Wiviott SD; Giugliano RP; Blazing MA; Park JG; Murphy SA; White JA; Mach F; Van de Werf F; Dalby AJ; White HD; Tershakovec AM; Cannon CP; Braunwald E
Circulation; 2017 Dec; 136(25):2440-2450. PubMed ID: 28972004
[TBL] [Abstract][Full Text] [Related]
26. Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT.
Bohula EA; Giugliano RP; Cannon CP; Zhou J; Murphy SA; White JA; Tershakovec AM; Blazing MA; Braunwald E
Circulation; 2015 Sep; 132(13):1224-33. PubMed ID: 26330412
[TBL] [Abstract][Full Text] [Related]
27. Ezetimibe + statin: insufficient benefit.
Prescrire Int; 2016 Oct; 25(175):245-246. PubMed ID: 30645833
[TBL] [Abstract][Full Text] [Related]
28. Getting there: statin plus ezetimibe for low-density lipoprotein cholesterol goals.
Hurley DL; Isley WL
Mayo Clin Proc; 2005 May; 80(5):585-6. PubMed ID: 15887424
[No Abstract] [Full Text] [Related]
29. [Drug of the month. Ezetimibe/simvastatin tablet (Inegy)].
Scheen AJ; Radermecker RP
Rev Med Liege; 2007 Sep; 62(9):585-90. PubMed ID: 17966796
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
Katsiki N; Athyros VG; Karagiannis A; Mikhailidis DP
Int Angiol; 2011 Jun; 30(3):295; author reply 296. PubMed ID: 21617615
[No Abstract] [Full Text] [Related]
31. After ENHANCE: is more LDL cholesterol lowering even better?
Stein EA
Clin Chem; 2008 Jun; 54(6):940-2. PubMed ID: 18403568
[No Abstract] [Full Text] [Related]
32. [Cholesterol goals are now easier to reach. Half LDL cholesterol with only one tablet daily].
MMW Fortschr Med; 2005 Nov; 147(45):55. PubMed ID: 16320656
[No Abstract] [Full Text] [Related]
33. [ACUTE CORONARY SYNDROME AND LIPID-LOWERING THERAPY. DOES THE IMPROVE-IT STUDY MAKE ANY DIFFERENCE?].
Lancellotti P; Pierard LA; Scheen AJ
Rev Med Liege; 2015 Sep; 70(9):450-5. PubMed ID: 26638446
[TBL] [Abstract][Full Text] [Related]
34. LDL-Cholesterol is the King.
Goumas GS
Angiology; 2009; 60(3):387-8. PubMed ID: 19497926
[No Abstract] [Full Text] [Related]
35. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
[TBL] [Abstract][Full Text] [Related]
36. An update on the IMProved reduction of outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) design.
Califf RM; Lokhnygina Y; Cannon CP; Stepanavage ME; McCabe CH; Musliner TA; Pasternak RC; Blazing MA; Giugliano RP; Harrington RA; Braunwald E
Am Heart J; 2010 May; 159(5):705-9. PubMed ID: 20435175
[No Abstract] [Full Text] [Related]
37. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
[TBL] [Abstract][Full Text] [Related]
38. [IMPROVE-IT Study proves effectiveness of ezetimib. The Higgs particle of lipidologists].
Einecke D
MMW Fortschr Med; 2014 Dec; 156(21-22):24-6. PubMed ID: 25608385
[No Abstract] [Full Text] [Related]
39. IMPROVE-IT: what have we learned?
Banach M; Nikolic D; Rizzo M; Toth PP
Curr Opin Cardiol; 2016 Jul; 31(4):426-33. PubMed ID: 27218683
[TBL] [Abstract][Full Text] [Related]
40. Effect of ezetimibe coadministration with simvastatin in a Middle Eastern population: a prospective, multicentre, randomized, double-blind, placebo-controlled trial.
Zubaid M; Shakir DK; Bazargani N; Binbrek A; Gopal R; Al-Tamimi O; Bakir S
J Cardiovasc Med (Hagerstown); 2008 Jul; 9(7):688-93. PubMed ID: 18545068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]